Additional Proxy Soliciting Materials (definitive) (defa14a)
27 Abril 2023 - 3:13PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section
14(a) of the Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant
|
|
|
☒
|
Filed by a Party other than the Registrant
|
|
|
☐
|
Check the appropriate box:
☐
|
|
|
Preliminary Proxy Statement
|
☐
|
|
|
Confidential, for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2))
|
☐
|
|
|
Definitive Proxy Statement
|
☒
|
|
|
Definitive Additional Materials
|
☐
|
|
|
Soliciting Material Pursuant to § 240.14a-12
|
LYELL IMMUNOPHARMA, INC.
|
(Name of Registrant as Specified In Its Charter)
|
|
(Name of Person(s) Filing Proxy Statement if other than the Registrant)
|
Payment of Filing Fee (Check all boxes that apply):
☒
|
|
|
No fee required.
|
☐
|
|
|
Fee paid previously with preliminary materials
|
☐
|
|
|
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
14a-6(i)(1) and 0-11
|
Lyell Immunopharma (NASDAQ:LYEL)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Lyell Immunopharma (NASDAQ:LYEL)
Gráfica de Acción Histórica
De May 2023 a May 2024